Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - memantine hydrochloride 10mg; memantine hydrochloride 10mg - film coated tablet - 10 mg - active: memantine hydrochloride 10mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate methacrylic acid - ethyl acrylate copolymer microcrystalline cellulose polysorbate 80 purified talc   purified water simeticone sodium laurilsulfate triacetin active: memantine hydrochloride 10mg excipient: colloidal silicon dioxide croscarmellose sodium hypromellose iron oxide yellow macrogol 400 magnesium stearate microcrystalline cellulose titanium dioxide - treatment of patients with moderate to severe alzheimer's disease

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - memantine hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: titanium dioxide; lactose monohydrate; macrogol 8000; magnesium stearate; croscarmellose sodium; hypromellose; hyprolose; microcrystalline cellulose - treatment of the symptoms of moderately severe to severe alzheimer's disease

Tanzanija - angleščina - Tanzania Medicinces & Medical Devices Authority

unichem laboratories limited, india - memantine - film coated tablet - 10

Tanzanija - angleščina - Tanzania Medicinces & Medical Devices Authority

unichem laboratories limited, india - memantine - film coated tablet - 10

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - memantine hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; purified talc; titanium dioxide; hypromellose; macrogol 400 - treatment of the symptoms of moderately severe to severe alzheimer's disease

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - memantine hydrochloride, quantity: 20 mg - tablet, film coated - excipient ingredients: magnesium stearate; purified talc; microcrystalline cellulose; colloidal anhydrous silica; croscarmellose sodium; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 400 - treatment of the symptoms of moderately severe to severe alzheimer's disease

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - memantine hydrochloride, quantity: 20 mg - tablet, film coated - excipient ingredients: purified talc; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; colloidal anhydrous silica; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 400 - treatment of the symptoms of moderately severe to severe alzheimer's disease

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - memantine hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: magnesium stearate; purified talc; croscarmellose sodium; colloidal anhydrous silica; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 400 - treatment of the symptoms of moderately severe to severe alzheimer's disease

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

gm pharma international pty ltd - memantine hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; macrogol 8000; hyprolose; croscarmellose sodium; hypromellose; titanium dioxide; lactose monohydrate - treatment of the symptoms of moderately severe to severe alzheimer's disease

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

gm pharma international pty ltd - memantine hydrochloride, quantity: 10 mg - tablet, film coated - excipient ingredients: hypromellose; lactose monohydrate; croscarmellose sodium; titanium dioxide; macrogol 8000; microcrystalline cellulose; hyprolose; magnesium stearate - treatment of the symptoms of moderately severe to severe alzheimer's disease